Document is current
Any future updates will be listed below
-
Authors
Işık, Mehtap http://orcid.org/0000-0002-6789-952X
Levorse, Dorothy
Mobley, David L. http://orcid.org/0000-0002-1083-5533
Rhodes, Timothy http://orcid.org/0000-0001-7534-9221
Chodera, John D. http://orcid.org/0000-0003-0542-119X
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (R01GM124270, 1R01GM108889-01)
National Science Foundation (CHE 1352608)
- License Information
-
More Information
Article History
Received: 15 September 2019
Accepted: 7 December 2019
First Online: 19 December 2019
Compliance with ethical standards
:
: JDC was a member of the Scientific Advisory Board for Schrödinger, LLC during part of this study. JDC and DLM are current members of the Scientific Advisory Board of OpenEye Scientific Software. The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biosciences, XtalPi, the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, The Einstein Foundation, and the Sloan Kettering Institute. A complete list of funding can be found at ExternalRef removed.
